初次全关节置换术后早期阿片类药物剂量依赖性与假体周围感染及其他并发症相关
该研究基于Premier医疗数据库纳入2004至2014年接受初次择期全髋或全膝关节置换的成人患者1,525,985例,量化术后前3天阿片消耗量(标准化为吗啡毫克当量MME)并分为五组。多因素分析显示,MME暴露增加与假体周围感染及静脉血栓栓塞事件风险呈剂量依赖性升高。
要点
- 术后早期阿片用量越高,假体周围感染和静脉血栓栓塞风险呈剂量依赖性增加。
- 与<54 MME组相比,>172 MME组假体周围感染aOR为1.37(95%CI 1.33-1.42)。
- >172 MME组深静脉血栓栓塞aOR为1.34(95%CI 1.30-1.38),肺栓塞aOR为1.29(95%CI 1.25-1.34)。
核心结论
- 全髋或全膝关节置换术后早期阿片用量增加与假体周围感染和静脉血栓栓塞事件风险呈剂量依赖性升高相关。
研究设计与样本
- 回顾性队列研究,查询Premier医疗数据库,纳入2004至2014年接受初次择期全髋或全膝关节置换的成人患者1,525,985例,量化术后前3天阿片消耗量并标准化为MME,按MME暴露分为五组:<54、54至82、83至116、117至172、>172 MME。
主要发现
- 与<54 MME组相比,>172 MME组假体周围感染aOR为1.37(95%CI 1.33至1.42)。
- 与<54 MME组相比,>172 MME组深静脉血栓栓塞aOR为1.34(95%CI 1.30至1.38),肺栓塞aOR为1.29(95%CI 1.25至1.34)。
- 与<54 MME组相比,>172 MME组肺部并发症aOR为1.06(95%CI 1.05至1.08)。
- 与<54 MME组相比,>172 MME组伤口感染aOR为1.37(95%CI 1.33至1.41),伤口裂开aOR为1.24(95%CI 1.19至1.31)。
- 与<54 MME组相比,>172 MME组30天再入院aOR为1.21(95%CI 1.20至1.22),90天再入院aOR为1.20(95%CI 1.19至1.21)。
关键数值与推荐
- MME分组界值:<54、54至82、83至116、117至172、>172 MME。
- 主要结局包括术后假体周围感染、肺栓塞、深静脉血栓和肺部并发症;次要结局包括伤口感染、伤口裂开及术后30天和90天再入院。
临床怎么用
- 全髋或全膝关节置换术后早期应关注阿片类药物用量,高MME暴露(>172 MME)与假体周围感染及静脉血栓栓塞风险升高相关,或可据此优化术后镇痛方案。
局限性
- 证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioids are commonly prescribed for postoperative pain following total joint arthroplasty. Despite widespread use, few studies have examined the dose-dependent effect of perioperative opioid use on postoperative complications following total hip arthroplasty (THA) and total knee arthroplasty (TKA). Therefore, we examined the dose-dependent relationship between opioid use and postoperative complications following primary THA and TKA. METHODS: We queried the Premier Healthcare Database to identify adult patients who underwent primary elective THA or TKA from 2004 to 2014, and quantified opioid consumption within the first 3 postoperative days. Opioid consumption was standardized to morphine milligram equivalents (MMEs). Patients were divided into quintiles on the basis of MME exposure: <54, 54 to 82, 83 to 116, 117 to 172, and >172 MMEs. Primary outcomes included postoperative periprosthetic joint infection, pulmonary embolism, deep venous thrombosis, and pulmonary complications. Secondary outcomes included wound infection, wound dehiscence, and readmission within 30 and 90 days postoperatively. Univariate and multivariate analyses were performed to compare differences between groups and to account for confounders. RESULTS: A total of 1,525,985 patients were identified. The mean age was 65.7 ± 10.8 years, 598,320 patients (39.2%) were male, and 1,174,314 patients (77.0%) were Caucasian. On multiple logistic regression analysis, increasing MME exposure was associated with a dose-dependent increased risk of postoperative complications. Compared with patients receiving <54 MMEs, exposure to >172 MMEs was associated with greater odds of periprosthetic joint infection (adjusted odds ratio [aOR], 1.37; 95% confidence interval [CI], 1.33 to 1.42), deep venous thromboembolism (aOR, 1.34; 95% CI, 1.30 to 1.38), pulmonary embolism (aOR, 1.29; 95% CI, 1.25 to 1.34), and pulmonary complications (aOR, 1.06; 95% CI, 1.05 to 1.08). Exposure to >172 MMEs was associated with increased risk of wound infection (aOR, 1.37; 95% CI, 1.33 to 1.41), wound dehiscence (aOR, 1.24; 95% CI, 1.19 to 1.31), and readmission within 30 (aOR, 1.21; 95% CI, 1.20 to 1.22) and 90 days (aOR, 1.20; 95% CI, 1.19 to 1.21). CONCLUSIONS: Increasing opioid use within the early postoperative period following THA or TKA was associated with a dose-dependent increased risk of periprosthetic joint infection and venous thromboembolic events. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Chung BC, Bouz GJ, Mayfield CK, et al. Dose-Dependent Early Postoperative Opioid Use Is Associated with Periprosthetic Joint Infection and Other Complications in Primary TJA. J Bone Joint Surg Am. 2021. PMID: 34043598. doi:10.2106/JBJS.21.00045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。